Briacell Therapeutics Corp (NQ: BCTX )
0.7876
+0.0476
(+6.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Briacell Therapeutics Corp
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/20/bctx.png?width=1200&height=800&fit=crop)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
Exposures
Product Safety
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
Via Talk Markets
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://public.newsdirect.com/810130982/ZngKuwZX.png)
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Via TheNewswire.com
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/images/story/2022/12/13/screenshot_2022-12-13_at_4.40.52_pm.png?width=1200&height=800&fit=crop)
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 02, 2022
Via TheNewswire.com
Topics
Stocks
![](https://public.newsdirect.com/411918201/ZngKuwZX.png)
![](https://cdn.benzinga.com/files/images/story/2022/12/01/screenshot_2022-12-01_at_7.11.40_pm.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221130005423/en/1650736/4/bria93-for_globenewswire.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image22.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/06/medicinemsn1.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/chart16.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/analysis-gaf5e8c997_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2619.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_377.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.